• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Investigation of single and recurrent stone formers.

作者信息

Tiselius H G

机构信息

Department of Urology, University Hospital, Linköping, Sweden.

出版信息

Miner Electrolyte Metab. 1994;20(6):321-7.

PMID:7783694
Abstract

A routine programme for investigation of patients with renal stone disease is presented. The different steps in this process are determined by the stone composition and the patient's previous history of stone formation. Assessment of the supersaturation and the crystallization properties are carried out in urine collected during a 24-hour period in one 16-hour and one 8-hour sample. The programme described in this paper has been formulated with a therapeutic goal in mind, whereby expensive and unnecessary procedures are avoided.

摘要

相似文献

1
Investigation of single and recurrent stone formers.
Miner Electrolyte Metab. 1994;20(6):321-7.
2
[Functional evaluation in patients with kidney calculi].[肾结石患者的功能评估]
Srp Arh Celok Lek. 1998 Sep-Oct;126(9-10):394-8.
3
Reduced renal function and benefits of treatment in cystinuria vs other forms of nephrolithiasis.胱氨酸尿症与其他形式肾结石相比,肾功能降低及治疗的益处。
BJU Int. 2006 Jun;97(6):1285-90. doi: 10.1111/j.1464-410X.2006.06169.x.
4
Acetazolamide is an effective adjunct for urinary alkalization in patients with uric acid and cystine stone formation recalcitrant to potassium citrate.乙酰唑胺是一种有效的辅助药物,用于对枸橼酸钾治疗无效的尿酸和胱氨酸结石形成患者的尿液碱化。
Urology. 2008 Aug;72(2):278-81. doi: 10.1016/j.urology.2008.04.003. Epub 2008 Jun 4.
5
A study of dietary calcium and other nutrients in idiopathic renal calcium stone formers with low bone mineral content.一项关于骨矿物质含量低的特发性肾钙结石患者膳食钙及其他营养素的研究。
J Urol. 1998 Mar;159(3):654-7.
6
[Identification of lithogenic risk factors by a simplified first-line laboratory assessment in urinary calculi patients].[通过简化的一线实验室评估识别尿路结石患者的结石形成风险因素]
Prog Urol. 2006 Nov;16(5):542-5.
7
[Monitoring of the treatment of calcium-oxalate stone formers with the Bonn-Risk-Index].
Urologe A. 2003 Feb;42(2):243-9. doi: 10.1007/s00120-002-0246-7. Epub 2003 Jan 11.
8
Metabolic abnormalities associated with calyceal diverticular stones.与肾盏憩室结石相关的代谢异常。
BJU Int. 2006 May;97(5):1053-6. doi: 10.1111/j.1464-410X.2006.06134.x.
9
Role of stone analysis in metabolic evaluation and medical treatment of nephrolithiasis.结石分析在肾结石代谢评估及医学治疗中的作用
J Endourol. 2001 Mar;15(2):181-6. doi: 10.1089/089277901750134548.
10
Effect of acute acid loading on acid-base and calcium metabolism.急性酸负荷对酸碱及钙代谢的影响。
Scand J Urol Nephrol. 2006;40(1):35-44. doi: 10.1080/00365590500368344.

引用本文的文献

1
Papillary calcifications: a new prognostic factor in idiopathic calcium oxalate urolithiasis.乳头状钙化:特发性草酸钙尿结石的一个新的预后因素。
Urolithiasis. 2013 Nov;41(6):475-9. doi: 10.1007/s00240-013-0606-3. Epub 2013 Oct 8.
2
Assessment of crystallization risk formulas in pediatric calcium stone-formers.儿科钙结石形成者中结晶风险公式的评估。
Pediatr Nephrol. 2009 Oct;24(10):1997-2003. doi: 10.1007/s00467-009-1167-0. Epub 2009 Mar 31.
3
Patients' attitudes on how to deal with the risk of future stone recurrences.患者对于如何应对未来结石复发风险的态度。
Urol Res. 2006 Aug;34(4):255-60. doi: 10.1007/s00240-006-0056-2. Epub 2006 Apr 27.
4
Risk formulas in calcium oxalate urolithiasis.草酸钙尿路结石的风险公式。
World J Urol. 1997;15(3):176-85. doi: 10.1007/BF02201855.